Public signalCompany raiseAuto-indexed · Unverified
Epicrispr Biotechnologies, Inc. raised $176.8M
Epicrispr Biotechnologies, Inc.· SOUTH SAN FRANCISCO, US· Biotechnology· Filed Aug 26, 2026
Epicrispr Biotechnologies, Inc. reported raising capital. Based in SOUTH SAN FRANCISCO, CALIFORNIA, US. First sale reported 2018-05-04. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$176.8M
Confidence90%
On the record
- Location
- SOUTH SAN FRANCISCO, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $176.8M
- Target amount
- $212.8M
- Filing date
- Aug 26, 2026
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Sources & provenance
“Operating company sold 176,754,406 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Aug 26, 2026. Details beyond the filing have not been verified.
Tags
USCompanyBiotechnologyOver $100MCompany Raise
Are you associated with Epicrispr Biotechnologies, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record